CHICAGO (Reuters) - Delta Air Lines Inc (NYSE:DAL) is launching next week a program to test employees for active COVID-19 and antibodies under a partnership with the Mayo Clinic and Quest Diagnostics (NYSE:DGX) Inc, Chief Executive Ed Bastian said in an employee memo on Thursday.
Bastian did not say how many would initially be tested but said the program would "evolve into a full testing protocol – something that will be essential as we protect your health and begin the return to normal operations."